Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Fidia Spa ( (IT:FDA) ).
Fidia has announced that Global Growth Holding Limited has converted three bonds from the fifth tranche of its reserved convertible bond with warrants, at a price of €0.01 per share, resulting in the issuance of 3,000,000 new shares directly admitted to trading. Following this conversion, the company’s share capital will rise by €30,000 to €10,997,761.90, and the total number of shares will increase to 74,542,927, while 10 bonds in the fifth tranche remain subscribed but not yet converted, underscoring the ongoing execution of its planned capital increase package.
The partial conversion brings total POC subscriptions to a nominal €1,250,000 and related capital increases to €1,150,000, reflecting continued use of this financing tool to strengthen Fidia’s equity base. The move slightly dilutes existing shareholders but supports the company’s financial structure as it pursues its strategy in the high-performance milling and numerical control market, potentially enhancing its flexibility to invest and compete in the automotive and aerospace sectors.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global player in numerical control technology and high-performance integrated milling systems, serving mainly the automotive mould and aerospace sectors. With more than 50 years of experience and about 135 employees, the group provides complete solutions for the entire milling process, including numerical controls, high-speed milling machines and CAM software for complex shapes.
YTD Price Performance: -89.17%
Average Trading Volume: 1,972,694
Technical Sentiment Signal: Strong Sell
Current Market Cap: €585.4K
See more data about FDA stock on TipRanks’ Stock Analysis page.